CPAP Tested for High Blood Pressure When Lying Down in Autonomic Failure
Tests CPAP for lying-down high blood pressure in autonomic failure.
Key facts
- Who runs it
- Vanderbilt University Medical Center
- Where
- Nashville, United StatesSee the site
- Trial code
- Registry title
- CPAP for the Treatment of Supine Hypertension
- Status
- Recruiting
- People taking part
- 59 people, planned
- Started
- 23 Jun 2022
- Expected to end
- 31 Aug 2027
- Type of study
- Interventional, 5 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active CPAP
- Sham CPAP
- Sleeping in a head-up tilt (HUT) position
- Record updated
- 7 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 40-80 with autonomic failure, low blood pressure on standing and high blood pressure when lying down at night. It tests CPAP on night-time blood pressure.
- Age
- 40 to 80 years
- Sex
- Men and women
- Disease stage
- Autonomic failure (pure autonomic failure, multiple system atrophy or Parkinson disease) with neurogenic orthostatic hypotension (a drop of 20 mmHg or more in systolic blood pressure within 3 minutes of standing) and night-time supine hypertension (systolic blood pressure of 140 mmHg or more).
- Earlier treatment
- People must be able to stop their medication for the study. They must not have had recent facial trauma or surgery, or problems tolerating CPAP or the CPAP mask.
- Biomarker or test result
- Autonomic reflex testing showing impaired reflexes. Night-time systolic blood pressure of 140 mmHg or more during the overnight screening.
Main reasons for not taking part
- Recent facial trauma or surgery, or cannot tolerate CPAP or the mask
- Cannot tolerate stopping medication, or blood pressure stays at 180/110 mmHg or higher when lying down
- Bedridden, or cannot stand because of movement problems or severe orthostatic hypotension
- Smokers, pregnant women, unstable coronary artery disease or heart failure
- Major heart, blood vessel or nervous system event in the past 6 months
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Male and female subjects, age 40-80 years, with autonomic failure including pure autonomic failure, multiple system atrophy and Parkinson disease
- Neurogenic orthostatic hypotension, defined as a ≥20-mmHg decrease in systolic blood pressure within 3 minutes of standing associated with impaired autonomic reflexes determined by autonomic testing in the absence of other identifiable causes
- Nocturnal supine hypertension (nighttime systolic blood pressure ≥140 mmHg) during the overnight screening for supine hypertension
- Patients who are willing and able to provide informed consent
Who cannot take part
- Patients who cannot tolerate the medication withdrawal, defined as those who are unable to stand for at least one minute or those with sustained supine blood pressure ≥180/110 mmHg after the medication withdrawal period
- Patients with history of recent facial trauma or surgery or intolerance to CPAP or to the CPAP mask
- Bedridden patients or those who are unable to stand due to motor impairment or severe orthostatic hypotension
- Smokers, patients who are pregnant, or have clinically unstable coronary artery disease, or major cardiovascular or neurological event in the past 6 months; heart failure; and other factors which in the investigator's opinion would prevent the subject from completing the protocol including clinically significant abnormalities in clinical or laboratory testing
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Where in United States
- Autonomic Dysfunction Center/ Vanderbilt University Medical CenterNashville, United StatesContact: Bonnie K Black, RN, NPTaking people
About the trial
What the trial wants to find out
This study aims to learn about the effects of continuous positive airway pressure (CPAP) on people with autonomic failure and high blood pressure when lying down (supine hypertension) to determine if it can be used to treat their high blood pressure during the night. CPAP (a widely used treatment for sleep apnea) involves using a machine that blows air into a tube connected to a mask covering the nose, or nose and mouth, to apply a low air pressure in the airways.
Read full original descriptionShow less
The study includes 3-5 days spent in the Vanderbilt Clinical Research Center (CRC): at least one day of screening tests, followed by up to 3 study days. Subjects may be able to participate in daytime and/or overnight studies. The Daytime study consists of 2 study days: one with active CPAP and one with sham CPAP applied for up to 2 hours. The Overnight study consists of 3 study nights: one with active CPAP, one with sham CPAP, both applied for up to 9 hours and one night sleeping with the bed tilted head-up.
The 5 groups in the trial
- Active CPAP (Daytime Study)Treatment being tested
CPAP at 8, 10, or 12 cm H2O is applied for up to 2 hours while supine and awake.
Treatment: Active CPAP
- Sham CPAP (Daytime Study)Sham treatment, for comparison
Sham CPAP is applied for up to 2 hours while supine and awake.
Treatment: Sham CPAP
- Active CPAP (Overnight Study)Treatment being tested
CPAP at 8, 10, or 12 cm H2O is applied for up to 9 hours during the night.
Treatment: Active CPAP
- Sham CPAP (Overnight Study)Sham treatment, for comparison
Sham CPAP is applied for up to 9 hours during the night.
Treatment: Sham CPAP
- Sleeping in a head-up tilt position (Overnight Study)Existing treatment, for comparison
Sleeping with the bed tilted head-up by 10 degrees for up to 9 hours during the night.
Treatment: Sleeping in a head-up tilt (HUT) position
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension
- Plain-language title
- CPAP Tested for High Blood Pressure When Lying Down in Autonomic FailureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05489575, who can take part
- Record updated
- 7 April 2026